Cytotoxicity of Metallic Complexes of Furan Oximes in Murine and Human Tissue Cultured Cell Lines
暂无分享,去创建一个
[1] I. Hall,et al. The Cytotoxicity of 2‐Formyl and 2‐Acetyl‐(6‐picolyl)‐4N‐Substituted Thiosemicarbazones and Their Copper(II) Complexes , 1998, Archiv der Pharmazie.
[2] I. Hall,et al. The synthesis and antitumor activity of metal complexes of amine-carboxyborane adducts , 1998 .
[3] F. Bouet,et al. Cytotoxicity of copper complexes of 2-furaldehyde oxime derivatives in murine and human tissue cultured cell lines. , 1997, Anticancer research.
[4] I. Hall,et al. Antineoplastic and Cytotoxic Activities of Nickel(II) Complexes of Thiosemicarbazones , 1997, Metal-Based Drugs.
[5] I. Hall,et al. The cytotoxicity of copper(II) complexes of heterocyclic thiosemicarbazones and 2-substituted pyridine N-oxides. , 1993, Anti-cancer drugs.
[6] I. Hall,et al. The cytotoxicity of heterocyclic thiosemicarbazones and their metal complexes on human and murine tissue culture cells. , 1993, Anti-cancer drugs.
[7] N. Osheroff,et al. Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4'-(9-acridinylamino)methane-sulfon-m-anisidide. , 1992, Cancer research.
[8] Z. Darżynkiewicz,et al. Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells. , 1992, Cancer research.
[9] Harker Wg,et al. Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II beta isoform. , 1991 .
[10] T. Andoh,et al. Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives. , 1991, Cancer research.
[11] K. Morse,et al. DNA interaction with metal complexes and salts of substituted boranes and hydroborates in murine and human tumor cell lines. , 1991, Anti-cancer drugs.
[12] G. Ibrahim,et al. Metallic complexes with furan oximes. Part 5 - synthesis and characterization of 5-nitro-2-furfuraldoxime complexes with 3d element dihalides , 1990 .
[13] G. Bouet,et al. Complexes with furan oximes. Part III. Synthesis and characterization of 3-(2-furyl) 2-propene aldoxime and 3-(5-methyl 2-furyl) 2-propene aldoxime complexes with 3d element dihalides , 1989 .
[14] W. Clegg,et al. Nickel complexes of 1-methylimidazoline-2(3H)-thione: crystal structures of trans-dichlorotetrakis(1-methylimidazoline-2(3H)-thione)nickel(II) and tetrakis[1-methylimidazoline-2(3H)-thione]nickel(II) tetrafluoroborate , 1989 .
[15] D. W. Fry,et al. Inhibition of type II topoisomerase by fostriecin. , 1988, Biochemical pharmacology.
[16] N. Osheroff,et al. Phosphorylation of DNA topoisomerase II in vivo and in total homogenates of Drosophila Kc cells. The role of casein kinase II. , 1988, The Journal of biological chemistry.
[17] K. Rose. DNA topoisomerases as targets for chemotherapy , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] K. Lee,et al. Antimalarial agents. III. Mechanism of action of artesunate against Plasmodium berghei infection. , 1987, Chemical & pharmaceutical bulletin.
[19] L. Liu,et al. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II. , 1986, Cancer research.
[20] A. McPhail,et al. Antineoplastic activity of tetrakis-mu-(trimethylamine-boranecarboxylato)-bis (trimethylamine-carboxyborane)dicopper (II) in Ehrlich ascites carcinoma. , 1984, Journal of pharmaceutical sciences.
[21] L. Liu,et al. Cleavage of DNA by mammalian DNA topoisomerase II. , 1983, The Journal of biological chemistry.
[22] T. Beerman,et al. Induction of deoxyribonucleic acid damage in HeLa S3 cells by cytotoxic and antitumor sesquiterpene lactones. , 1981, Biochemical pharmacology.
[23] C. Rawlings,et al. Quantitative aspects of the formation and loss of DNA interstrand crosslinks in Chinese hamster cells following treatment with cis-diamminedichloroplatinum(II) (cisplatin). II. Comparison of results from alkaline elution, DNA renaturation and DNA sedimentation studies. , 1981, Biochimica et biophysica acta.
[24] L. Liu,et al. A homogeneous type II DNA topoisomerase from HeLa cell nuclei. , 1981, The Journal of biological chemistry.
[25] D. Hunting,et al. Determination of deoxyribonucleoside triphosphates using DNA polymerase: a critical evaluation. , 1981, Canadian journal of biochemistry.
[26] L. Liu,et al. Novel topologically knotted DNA from bacteriophage P4 capsids: studies with DNA topoisomerases. , 1981, Nucleic acids research.
[27] R. Christopherson,et al. An overall radioassay for the first three reactions of de novo pyrimidine biosynthesis. , 1981, Analytical biochemistry.
[28] C. Benz,et al. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. , 1981, The Journal of biological chemistry.
[29] N. Tanaka,et al. Mechanism of action of macromomycin: DNA strand scission, inhibition of DNA synthesis and mitosis. , 1978, The Journal of antibiotics.
[30] D. Eichler,et al. Effect of calcium on the recovery and distribution of DNA polymerase alpha from cultured human cells. , 1977, The Journal of biological chemistry.
[31] A. Leibovitz,et al. Classification of human colorectal adenocarcinoma cell lines. , 1976, Cancer research.
[32] S. Osaki,et al. Synthetic inhibitors of Escherichia coli, calf thymus, and Ehrlich ascites tumor thymidylate synthetase. , 1976, Journal of medicinal chemistry.
[33] G. Russev,et al. Some pyrazoles as inhibitors of purine biosynthesis de novo. , 1976, Biochemical pharmacology.
[34] S. Horwitz,et al. Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis. , 1976, Molecular pharmacology.
[35] K. Anderson,et al. Solubilized DNA-dependent nuclear RNA polymerases from the mammary glands of late-pregnant rats. , 1975, Biochimica et biophysica acta.
[36] C. Piantadosi,et al. Cycloalkanones. 4. Antifertility activity. , 1974, Journal of medicinal chemistry.
[37] M. Sasada,et al. Effect of neocarzinostatin on DNA synthesis in L1210 cells. , 1974, Cancer research.
[38] M. Hakala,et al. 5-(1-Adamantyl) pyrimidines as inhibitors of folate metabolism. , 1972, Cancer research.
[39] L. R. Finch,et al. Quantitative extraction and estimation of intracellular nucleoside triphosphates of Escherichia coli. , 1972, Analytical Biochemistry.
[40] A. Dobrjansky,et al. A rapid method for the isolation of nuclei from Ehrlich ascites tumor cells. , 1970, Cancer research.
[41] M. Chu,et al. The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y). , 1968, Biochemical pharmacology.
[42] Moore Ec,et al. Regulation of Mammalian Deoxyribonucleotide Biosynthesis by Nucleotides as Activators and Inhibitors , 1966 .
[43] T. Brzozowski,et al. Purification and properties of a bacterial carbamyl phosphate synthetase. , 1966, The Journal of biological chemistry.
[44] S. Ochoa,et al. Enzymatic phosphorylation of deoxycytidylic acid. , 1958, The Journal of biological chemistry.
[45] P. Cohen,et al. Colorimetric determination of carbamylamino acids and related compounds. , 1954, The Journal of biological chemistry.
[46] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[47] R. Archibald. DETERMINATION OF CITRULLINE AND ALLANTOIN AND DEMONSTRATION OF CITRULLINE IN BLOOD PLASMA , 1944 .